Zimmer Biomet Holdings Company Profile (NYSE:ZBH)

About Zimmer Biomet Holdings

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ZBH
  • CUSIP:
Key Metrics:
  • Previous Close: $116.38
  • 50 Day Moving Average: $115.72
  • 200 Day Moving Average: $116.44
  • 52-Week Range: $200,399,000.00 - $95.44
  • Trailing P/E Ratio: 77.95
  • Foreward P/E Ratio: 12.46
  • P/E Growth: 1.40
  • Market Cap: $23.43B
  • Outstanding Shares: 200,399,000
  • Beta: 1.2
  • Net Margins: 3.90%
  • Return on Equity: 16.66%
  • Return on Assets: 6.07%
  • Debt-to-Equity Ratio: 1.11%
  • Current Ratio: 1.95%
  • Quick Ratio: 1.13%
Additional Links:
Companies Related to Zimmer Biomet Holdings:

Analyst Ratings

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (?)
Ratings Breakdown: 3 Hold Ratings, 18 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.91)
Consensus Price Target: $133.68 (14.34% upside)

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
DateFirmActionRatingPrice TargetDetails
2/17/2017Needham & Company LLCReiterated RatingStrong-Buy$151.00View Rating Details
1/31/2017Canaccord GenuitySet Price TargetBuy$144.00View Rating Details
2/1/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$126.00 -> $132.00View Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00View Rating Details
2/1/2017RBC Capital MarketsBoost Price TargetOutperform$130.00 -> $133.00View Rating Details
2/1/2017Royal Bank of CanadaBoost Price TargetOutperform$130.00 -> $133.00View Rating Details
1/5/2017J P Morgan Chase & CoSet Price TargetBuy$134.00View Rating Details
11/29/2016Citigroup Inc.UpgradeSell -> NeutralView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralView Rating Details
11/1/2016Leerink SwannReiterated RatingOutperform$150.00 -> $136.00View Rating Details
11/1/2016Jefferies Group LLCLower Price TargetBuy$150.00 -> $129.00View Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00View Rating Details
8/23/2016Barclays PLCBoost Price TargetOverweight$140.00 -> $145.00View Rating Details
8/11/2016SunTrust Banks, Inc.Initiated CoverageBuy$155.00View Rating Details
7/29/2016BMO Capital MarketsReiterated RatingBuy$146.00View Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00View Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$125.00View Rating Details
6/8/2016Morgan StanleyReiterated RatingBuyView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Lower Price Target$113.00 -> $111.00View Rating Details
3/20/2016Bank of America CorpInitiated CoverageBuy$127.00View Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00View Rating Details
1/31/2016William BlairReiterated RatingOutperformView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00View Rating Details
10/30/2015Brean CapitalReiterated RatingHoldView Rating Details
10/9/2015Credit Suisse GroupInitiated CoverageOutperform$107.00View Rating Details
7/29/2015Deutsche Bank AGReiterated RatingHold$114.00View Rating Details
(Data available from 2/27/2015 forward)


Earnings History for Zimmer Biomet Holdings (NYSE:ZBH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZBH)
Current Year EPS Consensus Estimate: $8.56 EPS
Next Year EPS Consensus Estimate: $9.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.91$1.97$1.93
Q2 20166$1.96$2.14$2.00
Q3 20166$1.76$1.88$1.80
Q4 20166$2.09$2.17$2.13
Q1 20175$2.10$2.13$2.11
Q2 20175$2.11$2.21$2.16
Q3 20175$1.95$2.01$1.98
Q4 20175$2.32$2.41$2.37
Q1 20183$2.32$2.34$2.33
Q2 20183$2.36$2.39$2.38
Q3 20182$2.13$2.16$2.15
Q4 20182$2.52$2.58$2.55
(Data provided by Zacks Investment Research)


Current Dividend Information for Zimmer Biomet Holdings (NYSE:ZBH)
Annual Dividend:$0.96
Dividend Yield:0.82%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:65.31% (Based on Trailing 12 Months of Earnings)
11.21% (Based on Current Year Consensus EPS Estimate)
10.23% (Based on Next Year Consensus EPS Estimate)

Dividend History for Zimmer Biomet Holdings (NYSE:ZBH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Ownership Percentage: 1.22%
Institutional Ownership Percentage: 86.62%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.36View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.87View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.43View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.00View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Zimmer Biomet Holdings (NYSE:ZBH)
News IconEarnings Analysis & Update for Zimmer Biomet Holdings Inc (NYSE:ZBH)? (NYSE:ZBH)
prensariotiretail.com - February 25 at 4:37 AM
News IconZimmer Biomet Holdings Inc (NYSE:ZBH)
giftedviz.com - February 25 at 4:37 AM
News IconZimmer Biomet Holdings' (ZBH) Strong-Buy Rating Reiterated at Needham & Company LLC (NYSE:ZBH)
www.graffiotech.com - February 25 at 4:37 AM
News IconFiscal Year Earnings Estimate on Zimmer Biomet Holdings, Inc.(ZBH) (NYSE:ZBH)
mundoaguaysaneamiento.net - February 25 at 4:37 AM
News IconZimmer Biomet Holdings, Inc. (ZBH) Shares Sold by Keybank National Association OH (NYSE:ZBH)
hoyentv.com - February 25 at 4:37 AM
News IconZimmer Biomet Holdings, Inc. (ZBH) Position Boosted by FIL Ltd (NYSE:ZBH)
techknowbits.com - February 25 at 4:37 AM
finance.yahoo.com logoZimmer Biomet Holdings to Present at the Cowen and Company 37th Annual Health Care Conference (NYSE:ZBH)
finance.yahoo.com - February 25 at 4:36 AM
News IconThe Glenview Trust Co Invests $468000 in Zimmer Biomet Holdings, Inc. (ZBH) (NYSE:ZBH)
oakridgeobserver.com - February 24 at 12:38 AM
News IconStock Watch: Tracking the Levels for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Providence Standard (NYSE:ZBH)
providencestandard.com - February 23 at 4:09 AM
News IconFiscal Year Earnings Estimate on Zimmer Biomet Holdings, Inc.(ZBH) - Money Flow Index & Trends (NYSE:ZBH)
www.moneyflowtrends.com - February 23 at 4:09 AM
News IconToday Analysts Focus on Zimmer Biomet Holdings, Inc. (ZBH), Thermo Fisher Scientific Inc. (TMO) - StockNewsJournal (NYSE:ZBH)
stocknewsjournal.com - February 21 at 4:21 PM
News IconVictor Berggren, Chief Technology Officer & Colin Roe, Chief Services Officer of Global Convergence, Inc., Recognized as 2017 CRN® Channel Chiefs (NYSE:ZBH)
www.econotimes.com - February 20 at 7:44 PM
News Icon4G LTE (Long Term Evolution) 2014-2022 - Global Strategic Business Report 2017 (NYSE:ZBH)
www.econotimes.com - February 20 at 8:00 AM
News IconZimmer Biomet announces international release of procedure for bone marrow lesions (NYSE:ZBH)
www.healio.com - February 19 at 7:40 PM
News IconEquity Rundown: Checking the Levels for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Midway Monitor (NYSE:ZBH)
midwaymonitor.com - February 11 at 6:47 AM
thestreet.com logoHere's How the Tom Price Stock Portfolio Is Performing Now That He Is Confirmed (NYSE:ZBH)
www.thestreet.com - February 11 at 6:47 AM
sg.finance.yahoo.com logoSmith & Nephew hurt by tough markets in China and Gulf states (NYSE:ZBH)
sg.finance.yahoo.com - February 9 at 6:53 AM
News IconBlackRock Advisors LLC Raises Position in Zimmer Biomet Holdings, Inc. (ZBH) (NYSE:ZBH)
mundoaguaysaneamiento.net - February 7 at 9:19 PM
us.rd.yahoo.com logoZimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure (NYSE:ZBH)
us.rd.yahoo.com - February 7 at 9:19 PM
finance.yahoo.com logoZimmer Biomet Holdings to Present at the LEERINK Partners 6th Annual Global Healthcare Conference (NYSE:ZBH)
finance.yahoo.com - February 7 at 4:18 PM
News IconZimmer Biomet Holdings, Inc. (NYSE:ZBH) from Medical Appliances & Equipment – Todays Top Gains (NYSE:ZBH)
twincountynews.com - February 4 at 7:22 AM
News IconThe Zimmer Biomet Holdings Inc. (ZBH) Position Cut by UBS Group AG (NYSE:ZBH)
ekosvoice.com - February 3 at 6:55 AM
streetinsider.com logoZimmer (ZBH) Receives FDA Approval of Expanded 26-week Efficacy Claim for Gel-One Cross-Linked Hyaluronate to ... - StreetInsider.com (NYSE:ZBH)
www.streetinsider.com - February 2 at 6:58 AM
News IconRBC Capital Mkts Just Issued "Outperform" Rating on Zimmer Biomet Holdings Inc (ZBH) - Highland Mirror (NYSE:ZBH)
www.highlandmirror.com - February 2 at 6:58 AM
finance.yahoo.com logoZimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis (NYSE:ZBH)
finance.yahoo.com - February 2 at 6:57 AM
finance.yahoo.com logo4:31 pm Zimmer Biomet announces that the FDA has approved an expanded 26-week efficacy claim for its single-injection viscosupplement Gel-One Cross-Linked Hyaluronate for treatment of pain associated with knee osteoarthritis (NYSE:ZBH)
finance.yahoo.com - February 2 at 6:57 AM
seekingalpha.com logoZimmer Biomet Holdings' (ZBH) CEO David Dvorak on Q4 2016 Results - Earnings Call Transcript (NYSE:ZBH)
seekingalpha.com - February 1 at 7:36 AM
News IconTop Gainers of the Day: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) from Medical Appliances & Equipment (NYSE:ZBH)
twincountynews.com - February 1 at 7:36 AM
News IconWhat Analyst Recommend Regarding Stock of: Zimmer Biomet Holdings, Inc.'s (ZBH) (NYSE:ZBH)
brassale.net - February 1 at 7:36 AM
News IconZimmer Biomet Holdings, Inc. (ZBH) Position Decreased by Decatur Capital Management Inc (NYSE:ZBH)
mundoaguaysaneamiento.net - February 1 at 7:36 AM
News IconZimmer Biomet Holdings, Inc. (ZBH) Position Maintained by Pettee Investors Inc (NYSE:ZBH)
prensariotiretail.com - February 1 at 7:36 AM
News IconThe Selway Asset Management Reduces Stake in Zimmer Biomet Holdings Inc. (ZBH) (NYSE:ZBH)
eleganthomesinla.com - February 1 at 7:36 AM
News IconNYSE:ZBH Investor Alert: Deadline in Lawsuit against Zimmer Biomet Holdings Inc upcoming (NYSE:ZBH)
www.groundreport.com - February 1 at 7:36 AM
finance.yahoo.com logoEdited Transcript of ZBH earnings conference call or presentation 31-Jan-17 1:00pm GMT (NYSE:ZBH)
finance.yahoo.com - February 1 at 7:36 AM
4-traders.com logoZimmer Biomet : beats 4Q profit forecasts (NYSE:ZBH)
www.4-traders.com - January 31 at 8:18 AM
us.rd.yahoo.com logoJANUARY 31 ZBH INVESTOR DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Zimmer Biomet Holdings, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
us.rd.yahoo.com logoDEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Zimmer Biomet Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 31, 2017 – ZBH (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
us.rd.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Zimmer Biomet Holdings, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
us.rd.yahoo.com logoJANUARY 31 DEADLINE FOR ZBH INVESTORS: Lundin Law PC Announces Securities Class Action Lawsuit against Zimmer Biomet Holdings, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
biz.yahoo.com logoQ4 2016 Zimmer Biomet Holdings Inc Earnings Release - 07:30 am ET (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
us.rd.yahoo.com logo7:32 am Zimmer Biomet beats by $0.03, reports revs in-line; guides FY17 EPS in-line, revs in-line (NYSE:ZBH)
us.rd.yahoo.com - January 31 at 8:18 AM
sg.finance.yahoo.com logoZimmer beats 4Q profit forecasts (NYSE:ZBH)
sg.finance.yahoo.com - January 31 at 8:18 AM
biz.yahoo.com logoZimmer Biomet Holdings Inc Earnings Call scheduled for 8:00 am ET today (NYSE:ZBH)
biz.yahoo.com - January 31 at 8:18 AM
News IconBlackhill Capital Inc Cuts Position in Zimmer Biomet Holdings Inc (ZBH) by $12671198 - Highland Mirror (NYSE:ZBH)
www.highlandmirror.com - January 29 at 7:02 AM
News IconSell-side Taking Aim at Shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) - Aiken Advocate (NYSE:ZBH)
aikenadvocate.com - January 27 at 6:55 AM
News IconZimmer Biomet Holdings, Inc. (ZBH) Position Boosted by Winslow Capital Management LLC (NYSE:ZBH)
larampadinapoli.com - January 26 at 6:38 AM
4-traders.com logoDeadline Upcoming in Lawsuit for Certain Investors Who Purchase Shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) (NYSE:ZBH)
www.4-traders.com - January 25 at 2:04 AM
us.rd.yahoo.com logoDEADLINE ALERT: Brower Piven Reminds Investors Of The January 31, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Zimmer Biomet Holdings, Inc. To Contact The Firm (NYSE:ZBH)
us.rd.yahoo.com - January 24 at 9:04 PM
us.rd.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Zimmer Biomet Holdings, Inc. - ZBH (NYSE:ZBH)
us.rd.yahoo.com - January 24 at 9:04 PM
finance.yahoo.com logoZBH INVESTOR DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Zimmer ... - Yahoo Finance (NYSE:ZBH)
finance.yahoo.com - January 24 at 4:01 PM


What is Zimmer Biomet Holdings' stock symbol?

Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet Holdings pay dividends? What is the dividend yield for Zimmer Biomet Holdings?

Zimmer Biomet Holdings declared a quarterly dividend on Monday, December 19th. Stockholders of record on Friday, December 30th will be given a dividend of $0.24 per share on Friday, January 27th. This represents a $0.96 annualized dividend and a dividend yield of 0.82%. The ex-dividend date is Wednesday, December 28th.

Where is Zimmer Biomet Holdings' stock going? Where will Zimmer Biomet Holdings' stock price be in 2017?

22 brokers have issued 12 month target prices for Zimmer Biomet Holdings' stock. Their forecasts range from $95.00 to $155.00. On average, they expect Zimmer Biomet Holdings' stock price to reach $133.68 in the next year.

When will Zimmer Biomet Holdings announce their earnings?

Zimmer Biomet Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about Zimmer Biomet Holdings stock?

Here are some recent quotes from research analysts about Zimmer Biomet Holdings stock:

  • Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)
  • According to Zacks Investment Research, "Over the past six months, Zimmer Biomet traded neck on neck with the Zacks categorized Medical Product industry. However, situation deteriorated in late October with the company posting a disappointing third quarter 2016. Sluggish top-line show outside the U.S. significantly hampered the company’s overall performance. Poor sales in Knee also concern us. With the company lowering its full-year 2016 guidance, we expect this gloomy scenario to continue. On a positive note, we still look forward to the expected synergy from the recently completed LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. This transaction is also expected to drive significant financial benefits for the consolidated company post 2017." (12/16/2016)

  • J P Morgan Chase & Co analysts commented, "Zimmer’s re-acceleration continued into 2Q earnings as sales grew 4.5% pro- forma and 2.6% organic excluding an extra selling day. Organic growth came in well above the Street’s call for 1.6% organic growth and buy-side calls for 1.9% (see our recent survey here). The sales beat was broad based with each business performing in-line or better than Street estimates with Knees (+$2M), Hips (+$9M), SET (+$20M), and Dental (+$5M) as the standout performers in the quarter. While gross margins were lower than expected (70bps), this was tempered by in-line operating expense and a better than expected tax rate including benefits from the early adoption of ASU 2016-09 (+$0.01). When factoring in the better than expected top-line, this drove a $0.05 Cash EPS beat. With Zimmer’s turnaround tracking ahead of expectations, we reiterate our Overweight rating on the stock and raise our price target from $134 to $148 (Y/E 17), conservatively valuing the stock at 15x 2018 Cash EPS, a 20% discount to its peers." (7/29/2016)

Who owns Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (3.99%), FMR LLC (3.32%), Investec Asset Management LTD (1.06%), Hotchkis & Wiley Capital Management LLC (0.79%), Janus Capital Management LLC (0.59%) and Russell Investments Group Ltd. (0.49%). Company insiders that own Zimmer Biomet Holdings stock include Adam Rudolph Johnson, Blackstone Capital Partners V, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Stuart G Kleopfer and Tony W Collins.

Who sold Zimmer Biomet Holdings stock? Who is selling Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Orbimed Advisors LLC, Tudor Investment Corp Et Al, Calamos Advisors LLC, Credit Agricole S A, AQR Capital Management LLC and NN Investment Partners Holdings N.V.. Company insiders that have sold Zimmer Biomet Holdings stock in the last year include Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Stuart G Kleopfer and Tony W Collins.

Who bought Zimmer Biomet Holdings stock? Who is buying Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Janus Capital Management LLC, FIL Ltd, Empire Life Investments Inc., State Street Corp, Asset Management One Co. Ltd., Tourbillon Capital Partners L.P. and Federated Investors Inc. PA.

How do I buy Zimmer Biomet Holdings stock?

Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Zimmer Biomet Holdings stock cost?

One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $116.92.

Zimmer Biomet Holdings (NYSE:ZBH) Chart for Monday, February, 27, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Earnings History Chart

Earnings by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Dividend History Chart

Dividend Payments by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Last Updated on 2/27/2017 by MarketBeat.com Staff